Table 2. In Vitro Antiproliferative Effects (IC50, μM) of Compounds 7a–q against Panc-1, PC3, MDA-MB-231, and HDF Cell Linesa.
| compounds | R | Panc-1 | PC3 | MBA-MB-231 | HDF |
|---|---|---|---|---|---|
| 7a | H | 92.48 ± 0.05 | 91.25 ± 0.077 | 87.31 ± 0.063 | >100 |
| 7b | 3-OH | 73.48 + 0.055 | 84.44 + 0.062 | 84.61 + 0.067 | >100 |
| 7c | 2-Me | 60.63 ± 0.051 | 65.34 ± 0.052 | 66.17 ± 0.043 | >100 |
| 7d | 3-Me | 65 ± 0.047 | 72.35 ± 0.063 | 65.94 ± 0.051 | >100 |
| 7e | 4-Me | 48.10 ± 0.018 | 53.19 ± 0.024 | 65.47 ± 0.041 | >100 |
| 7f | 3-OMe | 69.12 ± 0.039 | 78.98 ± 0.058 | 64.47 ± 0.05 | >100 |
| 7g | 4-OMe | 60 ± 0.047 | 68.28 ± 0.039 | 61.01 ± 0.029 | >100 |
| 7h | 4-F | 66.4 ± 0.046 | 74.6 ± 0.051 | 70.62 ± 0.054 | >100 |
| 7i | 3-Cl | 21.4 + 0.016 | 30.01 ± 0.02 | 17.9 ± 0.014 | >100 |
| 7j | 4-Cl | 46.95 ± 0.021 | 57.91 ± 0.04 | 53.34 ± 0.037 | >100 |
| 7k | 3-Br | 58.19 ± 0.022 | 66.29 ± 0.037 | 62.01 ± 0.041 | >100 |
| 7l | 4-Br | 73.92 ± 0.043 | 60.04 ± 0.031 | 58.03 ± 0.04 | >100 |
| 7m | 3-NO2 | 12.54 ± 0.001 | 17.66 ± 0.012 | 13.14 ± 0.005 | >100 |
| 7n | 4-NO2 | 46.35 + 0.028 | 60.17 + 0.045 | 61.66 + 0.052 | >100 |
| 7o | 3-OMe-4-OH | 14.95 + 0.001 | 17.76 + 0.014 | 15.09 + 0.001 | >100 |
| 7p | 2,4-Cl2 | 72.48 ± 0.058 | 76.3 ± 0.046 | 81.84 ± 0.063 | >100 |
| 7q | 3,4,5-(OMe)3 | 72.81 ± 0.052 | 81.28 ± 0.06 | 67.4 ± 0.048 | >100 |
| etoposide | 24.35 ± 0.001 | 32.15 ± 0.021 | 30.63 ± 0.014 | >100 |
Values are the means of three replicates ± standard deviation (SD).
